Roxybond: payments to doctors
Payments that named Roxybond as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $179K
- Providers
- 2,225
- Transactions
- 6,480
- Average per transaction
- $28
The per-transaction average — $28 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,225 providers the average total is $80, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Protega Pharmaceutials Inc | $161,805 | 90.6% |
| Protega Pharmaceutials LLC | $16,754 | 9.4% |